• Product Description:

NOBOKIN is a nobel kinase inhibitor that decreases tumor cell proliferation. Main targets are receptor tyrosine kinase pathway such as VEGFR, PDGFR. FLT3, KIT, and RET pathway.

  • Product Features:

Product Name NOBOKIN
Generic Name Sorafenib Tosylate INN 200 mg
FDA Approved Indications
  • Unresectable Hepatocellular Carcinoma
  • Advanced Renal Cell Carcinoma
  • Advanced or Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma
Packaging NOBOKIN 200 mg tablets are supplied in alu-alu blister. Each commercial box of NOBOKIN contain 32’s (4X8’s) in alu-alu blister.
Prescribing Information NOBOKIN (PDF)